There is good news for people around the world battling the Corona epidemic. Pfizer Corona vaccine has been approved in the UK. With this approval, Britain has become the first Western country to approve COVID-19 Vaccine.
Vaccination of the National Health Service (NHS) personnel in Britain can be started on 7 December. Pfizer claims that its vaccine has been found to be more than 95 per cent effective in preventing Covid-19 infection.
Before Britain, Russia has also approved a vaccine here. On August 11, Russia’s President Vladimir Putin (Vladimir Putin) launched the world’s first corona vaccine. The name of this vaccine is Sputnik-V vaccine.
Pfizer has prepared Corona Vaccine in collaboration with German pharmaceutical company BioNotech. The news of the approval of the vaccine in Britain has seen a 2 per cent jump in Pfizer India stock. The UK last month asked its Medicine and Healthcare Products Regulatory Agency (MHRA) to review the Pfizer-BioNTech Coronavirus vaccine. Britain has ordered 40 million doses of the Pfizer-BioNtech two-shot vaccine. With the approval, the consignment of medicine has been sent to Britain.
The UK Vaccine Committee will decide how needy groups will get the vaccine first.
Pfizer-BioNTech and US-based biotech firm Moderna Vaccine have both claimed to be over 90 per cent effective.
Will Corona Vaccine reach India?
The use of this Pfizer vaccine in India has not been considered yet. If we talk about the use of Pfizer vaccine in India, then Corona patients will have to give two doses of the vaccine.
The cost of these two doses of Pfizer Vaccine is Rs 3,000. In addition, to store the vaccine of Pfizer company, a temperature of -70 degrees will be required.
Oxford Vaccine is more effective in India than Pfizer
In India, the Corona vaccine of Oxford is being developed by the Serum Institute of India in the name of Covishield.
The Oxford Vaccine trials have been conducted in two ways. In a trial, half the dose was given first in England and then a full dose a month later. This method, the vaccine was found to be up to 90 per cent effective. In another trial, two full doses of the vaccine were given in a month in Brazil. In this trial, the effect of the vaccine was seen up to 62 per cent.
The results of both methods have averaged 70 per cent. In medical science, 70 per cent of effective medicine is also considered good.
Doses of Oxford and AstraZeneca will cost between 1000 and 1200 rupees. This vaccine can be kept at a temperature of 2 to 8 degrees.